It functions as a critical pro-adipogenic factor at the cellular level, and its inhibition, as shown in knockout models, can protect against diet-induced obesity, inflammation, and associated metabolic dysregulation, positioning CPEB4 as a potential therapeutic target for metabolic diseases. Here, CPEB4 is linked to obesity due to melanocortin 4 receptor deficiency.